Search results
4 days ago · This publication also includes indices of prescription and OTC drug products by proprietary name (brand name or trade name) or, if no proprietary name exists, established name of the active ingredient and by applicant name, which have been abbreviated for this publication.
4 days ago · One way to do the research is to go to the website of the U.S. National Library of Medicine. You can type in a drug in the search box, and then click on the photo of the drug label. See example: Januvia 25 mg. If you look closely, you’ll notice that the drug was made in the UK. You can also call the drug company and just ask them.
3 days ago · Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. There are twelve patents protecting this drug. This drug has three hundred and twenty-nine patent family members in forty-eight countries. The generic ingredient in TRELEGY ELLIPTA is fluticasone furoate; umeclidinium bromide; vilanterol trifenatate.
2 days ago · Tyvaso is a drug marketed by United Therap and is included in two NDAs. There are eleven patents protecting this drug and one Paragraph IV challenge. This drug has thirty-five patent family members in nine countries. The generic ingredient in TYVASO is treprostinil.
5 days ago · BYETTA is protected by zero US patents and one FDA Regulatory Exclusivity. Based on analysis by DrugPatentWatch, the earliest date for a generic version of BYETTA is ⤷ Try a Trial. This potential generic entry date is based on INFORMATION ADDED TO SECTION 8.4 OF THE LABELING TO DESCRIBE THE RESULTS FROM PEDIATRIC STUDIES.
1 day ago · In 2006, illegally manufactured, non-pharmaceutical fentanyl often mixed with cocaine or heroin caused an outbreak of overdose deaths in the United States and Canada, heavily concentrated in the cities of Dayton, Ohio; Chicago, Illinois; Detroit, Michigan; and Philadelphia, Pennsylvania. Enforcement
2 days ago · It was first approved for medical use in the United States in 1985. Bupropion was originally called by the generic name amfebutamone, before being renamed in 2000. In 2021, it was the eighteenth most commonly prescribed medication in the United States, with more than 29 million prescriptions.
